Sebi approved a series of reforms to improve market efficiency and investor protection. Key changes include the return of exchange-based bu...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...

Bobby Charles has won Maine's Republican gubernatorial primary. He secured victory after ranked-choice voting runoffs. Charles is an attorn...

India faces economic vulnerabilities from external crises. Five reforms are proposed to build resilience. These include reducing gold and c...

Even in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...

Arunachal Pradesh has significantly eased business regulations. The state has streamlined processes across 51 areas, including land, enviro...

Chemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

India's market regulator, SEBI, plans to review its delisting rules. This move aims to simplify capital market processes for businesses. SE...

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...

Dabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

India's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...

The US Food and Drug Administration has placed Dabur India's factory on an import alert. This action follows an inspection that revealed si...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

India has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...